AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Krishna Nuggehalli Ravindra

Potentially inactive Last observed office action: April 2026 (4 months ago).

Examiner Krishna Nuggehalli Ravindra appears to be about average relative to their peer examiners. Their lifetime grant ratio is 8.3%, they average 1.33 office actions per granted patent, and their rejection profile is dominated by §103, with occasional §101 rejections and elevated §112 usage.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC About Average
Difficulty vs USPTO About Average
Average OA / Grant 1.33
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
2 years (2025-2026)
Tech Center
1600 - Biotechnology and Organic
Group
1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated
36
Granted Applications
3
Non-Granted Applications
33
Avg OA / Grant
1.33
Last OA Observed
April 2026 (4 months ago)
Art Units Seen
1636
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 8.3% 1.33
Art Unit 30 37.9% 2.20
Group 245 37.7% 2.18
Tech Center 1,365 38.5% 2.02
USPTO 16,347 53.5% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2025; examiner may not yet have been active in the available dataset.
2025 23 3 13.0%
2026 13 0 0.0%

3 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 35 5.7% 8.6% 45.7% 22.9%
2 13 0.0% 7.7% 69.2% 15.4%
3 3 0.0% 0.0% 66.7% 33.3%
5 1 0.0% 0.0% 100.0% 0.0%
6 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2024
5.4%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.